in-app purchases and subscriptions. “I’d say 90% of our revenue was ad-driven before we started to shift,” said Geoff Cook, CEO of The Meet Group, which owns a ...
Hosted on MSN1mon
FDA Says Shortage of Eli Lilly’s Zepbound Is Over, but Gives Compounders a Grace PeriodOthers were more critical. In an interview with Barron’s on Thursday afternoon, Geoff Cook, the CEO of the privately-held telehealth company Noom, which sells compounded semaglutide, said that ...
You can find this story in My Bookmarks.Or by navigating to the user icon in the top right.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback